Basketball legend, entrepreneur and entertainer Shaquille O'Neal partners with Lilly to shine a spotlight on moderate-to-severe obstructive sleep apnea (OSA), encouraging ...

Scientists at the Keck School of Medicine of USC, working within the Southern California Superfund Research and Training ...

Eli Lilly has a new partnership with NBA Hall of Famer and cultural icon Shaquille O’Neal to launch a nationwide campaign raising awareness about moderate-to-severe obstructive sleep apnea (OSA).

Shared biological, psychological, and social pathways put patients at risk for both, whether obesity or depression occurs ...

New research from the University of Auckland’s Liggins Institute suggests that a capsule containing healthy gut bacteria could potentially change the future of obesity treatment. Eight years ago, a gr ...

Using semaglutide or tirzepatide for less than 2 years can cost as much as a Roux-en-Y gastric bypass — a one-time procedure ...

There is considerable demand for specialist weight management services and growing pressure for access to these medications ...

Regardless of how much weight you lose, GLP-1 drugs like Wegovy and Ozempic could decrease major adverse cardiovascular ...

A clinical perspective on pet joint health, from the limits of supplements to the necessity of weight management.

Advice on managing severe obesity, including where eligibility criteria or medical history may preclude the use of ...

GLP-1 inhibitors, like tirzepatide, show promise in reducing AHI in OSA patients with obesity, as demonstrated in the SURMOUNT trials. Experts highlight the importance of integrating GLP-1s with diet ...

Deficiency of the gene melanocortin 4 receptor (MC4R) is linked with obesity among adults. A recent study has found that the same deficiency also leads to surprising outcomes such as reduced risk of ...